Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours

British Journal of Cancer

Volumn 78, Issue 2, 1998, Pages 215-220

  Nutt, J E ^a   Mellon, J K ^a,b   Qureshi, K ^a   Lunec, J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bladder tumour; Epidermal growth factor; Matrix metalloproteinase 1; RT112 cells; RT4 cells; Urine

Indexed keywords

COLLAGENASE; EPIDERMAL GROWTH FACTOR; GELATINASE A; MESSENGER RNA; METALLOPROTEINASE;

ARTICLE; BLADDER TUMOR; CANCER GRADING; CANCER GROWTH; CONTROLLED STUDY; CULTURE MEDIUM; ENZYMURIA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL LINE;

EID: 0031864540     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.467     Document Type: Article

References (35)

1. Angel P, Baumann I, Stein B, Delius H, Rahmsdorf HJ and Herrlich P (1987) 12-O-Tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol Cell Biol 7: 2256-2266
2. Benbow U and Brinckerhoff CF (1997) The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 15: 519-526
3. Brotherick I, Lennard TWJ, Wilkinson SE, Cook S, Angus B and Shenton BK (1994) Flow cytometric method for the measurement of epidermal growth factor receptor and comparison with the radio-ligand binding assay. Cytometry 16: 262-269
4. Church GM and Gilbert W (1984) Genomic sequencing. Proc Natl Acad Sci USA 81: 1991-1995
5. Clifford SC, Thomas DJ, Neal DE and Lunec J (1994) Increased mdr I gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay. Br J Cancer 69: 680-686
6. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A and Balkwill F (1993) Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53: 5365-5369
7. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJP, Angel P and Heath JK (1987) Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6: 1899-1904
8. Feinberg AP and Vogelstein B (1983) A technique for radiolabelling restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-13
9. Fisher DA and Lakshmanan J (1990) Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocrine Rev 11: 418-442
10. Fuse H, Mizuno I, Sakamoto M and Katayama T (1992) Epidermal growth factor in urine from the patients with urothelial tumors. Urol Int 48: 261-264
11. Gohji K, Fujimoto N, Fujii A, Komiyama T, Okawa J and Nakajima M (1996a) Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in tecurrence of urothelial cancer after complete resection. Cancer Res 56: 3196-3198
12. Gohji K, Fujimoto N, Komiyama T, Fujii A, Ohkawa J, Kamidono S and Nakajima M (1996b) Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma. Cancer 78: 2379-2387
13. Greene J, Wang M, Liu YE, Raymond LA, Rosen C and Shi YK (1996) Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 271: 30375-30380
14. Grignon DJ, Sakr W, Toth M, Ravery V, Angulo J, Shamsa F, Pontes JE, Crissman JC and Fridman R (1996) High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Cancer Res 56: 1654-1659
15. Kameyama K (1996) Expression of MMP-1 in the capsule of thyroid cancer - relationship with invasiveness. Path Res Pract 192: 20-26
16. Liotta LA, Steeg PS and Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336
17. Lipponen P and Eskelinen M (1994) Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors. oncoprotein (c-erbB-2. p53) expression and long-term prognosis. Br J Cancer 69: 1120-1125
18. Margulies IMK, Hoyhtya M, Evans C, Stracke ML, Liotta LA and Stetler-Stevenson WG (1992) Urinary type IV collagenase: elevated levels are associated with bladder transitional cell carcinoma. Cancer Epidemiol Biomark Prev 1: 467-474
19. Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodelling. TIG 6: 121-125
20. McDonnell SE, Kerr LD and Matrisian LM (1990) Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of protooncogenes c-fos and c-jun and activation of protein kinase C. Mol Cell Biol 10: 4284-4293
21. Mellon K, Wright C, Kelly P, Wilson-Horne CH and Neal DE (1995) Long-term outcome related to epidermal growth factor receptor status in bladder cancer. J Urol 153: 919-925
22. Muller D, Wolf C, Abecassis J, Millon R, Engelmann A, Bronner G, Rouyer N, Rio M-C, Eber M, Methlin G, Chambon P and Basset P (1993) Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas, Cancer Res 53: 165-169
23. Murray GI, Duncan ME, O'Neil P, Melvin WT and Fothergill JE (1996) Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nature Med 2: 461-462
24. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T and Okada Y (1994) Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81: 69-77
25. Nakopoulou L, Zervas A, Constantinides C, Gakiopoulou H, Tzonou A and Dimopoulos C (1997) Metalloproteinase-3 m-RNA and protein expression of metalloproteinase-1 and metalloproteinase-3 in transitional cell bladder cancer. Br J Urol 80 (suppl. 2): 68
26. Nartio S, Kanayama H, Aki M and Kagawu S (1993) Gene expression of type IV collagenase and tissue inhibitor of metalloproteinases (TIMP) in human bladder cancers. Jpn J Urol 84: 841-850
27. Naruo S, Kanayama H, Takigawa H, Kagawa S, Yamashita K and Hayakawa T (1994) Serum levels of a tissue inhibitor of metalloproteinases-1 (TIMP-1) in bladder cancer patients. Int J Urol 1: 228-231
28. Nomura H, Fujimoto N, Seiki M, Mai M and Okada Y (1996) Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int J Cancer 69: 9-16
29. Nutl JE and Lunec J (1996) Induction of metalloproteinase (MMP1) expression by epidermal growth factor (EGF) receptor stimulation and serum deprivation in human breast tumour cells. Eur J Cancer 32A: 2127-2135
30. Nutt JE, Harris AL and Lunec J (1991) Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-β1 genes in breast tumour cells Br. J Cancer 64: 671-676
31. Powell WC and Matrisian LM (1996) Complex roles of matrix metalloproteinases in tumor progression. In Current Topics in Microbiology and Immnunology. Gunthert U and Birchmeier W. (eds), 213 pp. 1-21. Springer: Berlin
32. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65
33. Shibata T, Kawano T, Nagayasu H, Okumura K, Arisue M, Hamada J, Takeichi N and Hosokawa M (1996) Enhancing effects epidermal growth factor on human squamous cell carcinoma motility and matrix degradation but not growth. Tumor Biol 17: 168-175
34. Stetler-Stevenson WG, Hewitt R and Corcoran M (1996) Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Cancer Biol 7: 147-154
35. Urbanski SJ, Edwards DR, Maitland A, Leco KJ, Watson A and Kossakowska AE (1992) Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer 66: 1188-1194